Epizyme, Inc.
Epizyme, Inc., a pioneering biopharmaceutical company headquartered in the United States, is at the forefront of developing innovative therapies for cancer and other serious diseases. Founded in 2008, Epizyme has made significant strides in the field of epigenetics, focusing on the discovery and development of small molecule drugs that target specific genetic mutations.
The company’s flagship product, Tazemetostat, is a first-in-class EZH2 inhibitor that has garnered attention for its unique mechanism of action and potential to treat various malignancies. With a strong commitment to advancing precision medicine, Epizyme has established a notable market position, particularly in the oncology sector, and continues to expand its pipeline of targeted therapies. Through its dedication to scientific excellence, Epizyme is shaping the future of cancer treatment and improving patient outcomes.
+25 vs industry average
Epizyme, Inc.’s score of 63 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Epizyme, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Epizyme, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Epizyme, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Epizyme, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Ipsen S.A.
Carbon Disclosure Project
Inherited from Ipsen S.A.The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Ipsen S.A.RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project